Full video transcriptClick to expand
Auto-generated transcript of @ricewashrepeat's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00Someone you had asked me for some direction. Here's what you do. Remove this gray cap
- 0:06Just by pulling it straight out. Once you remove it
- 0:09You are going to twist this on the unlock right here. It's a lock and unlock
- 0:16Place it in the area that you want to inject and here's this purple button
- 0:22What it does is you just click on it like a pen once it's done
- 0:25You're gonna hear a click and that's it. So here we go. That's it
- 0:45This is the easiest way to do your GOP one
- 0:49So far how you dispose of it is just by putting this back on. That's it and you hear that click
- 0:58And you're done
GLP-1 injection technique: what TikTok gets right and wrong
Quick answer
The video demonstrates injection technique for a GLP-1 receptor agonist auto-injector pen, likely intended for subcutaneous self-injection in patients managing type 2 diabetes or obesity. The tutorial covers cap removal, unlocking, site placement, and button activation, but omits hold time, dose confirmation, site rotation, and sharps disposal requirements, all of which are included in FDA-approved prescribing information for GLP-1 medications. Patients should follow the medication guide specific to their prescribed product and confirm technique with a pharmacist or prescriber.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For GLP-1 injection technique: what TikTok gets right and wrong, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference
A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.
PubMed
Discontinuing glucagon-like peptide-1 receptor agonists and body habitus
Used for pages discussing stopping therapy, weight regain, and long-term planning.
PubMed
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
GLP-1 injection technique: what TikTok gets right and wrong should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "GLP-1 injection technique: what TikTok gets right and wrong" from ricewashrepeat. We read the clip as a GLP-1 social video fact-checks claim about GLP-1 social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The video demonstrates injection technique for a GLP-1 receptor agonist auto-injector pen, likely intended for subcutaneous self-injection in patients managing type 2 diabetes or obesity.
The reason this review is not generic is the source wording and the canonical claim label "glp1 how to use a glp 1 pen the fear of needles doesn t just disa." In this clip, the useful excerpt is: "Someone you had asked me for some direction." That wording changes the review because it points to GLP-1 social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference (2025), Discontinuing glucagon-like peptide-1 receptor agonists and body habitus (2025), and Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition (2025), plus the creator's own wording. GLP-1 social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The video demonstrates injection technique for a GLP-1 receptor agonist auto-injector pen, likely intended for subcutaneous self-injection in patients managing type 2 diabetes or obesity.
FormBlends verdict
GLP-1 social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The video demonstrates injection technique for a GLP-1 receptor agonist auto-injector pen, likely intended for subcutaneous self-injection in patients managing type 2 diabetes or obesity. The tutorial covers cap removal, unlocking, site placement, and button activation, but omits hold time, dose confirmation, site rotation, and sharps disposal requirements, all of which are included in FDA-approved prescribing information for GLP-1 medications. Patients should follow the medication guide specific to their prescribed product and confirm technique with a pharmacist or prescriber.
- FDA-approved GLP-1 pen labeling requires holding the pen against the skin for roughly 10 seconds after clicking, a step the video omits entirely.
- Blanco et al. (2013, Diabetes Research and Clinical Practice) linked repeated injection into the same site to lipohypertrophy, which reduces drug absorption. Site rotation was not mentioned in this tutorial.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- FDA-approved GLP-1 pen labeling requires holding the pen against the skin for roughly 10 seconds after clicking, a step the video omits entirely.
- Blanco et al. (2013, Diabetes Research and Clinical Practice) linked repeated injection into the same site to lipohypertrophy, which reduces drug absorption. Site rotation was not mentioned in this tutorial.
- Used GLP-1 pens are sharps waste under FDA and CDC guidelines. Recapping and placing in household trash is not compliant and creates needle-stick risk.
- Brod et al. (2014) confirmed that injection-related fear is a real barrier to GLP-1 adherence, so the creator's reassurance framing has legitimate clinical backing.
- Drab et al. (2022, Diabetes Therapy) found injection technique errors were associated with worse glycemic control, meaning the steps a tutorial skips are not cosmetic details.
- Most pharmacies in the US offer sharps disposal containers or mail-back programs at low or no cost. Patients should ask their dispensing pharmacy.
- No TikTok tutorial replaces the medication guide packaged with your specific GLP-1 pen. Brand and device differences mean steps can vary in ways that affect dosing accuracy.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @ricewashrepeat actually say?
The creator walked through a GLP-1 auto-injector demo, telling viewers to remove the gray cap, twist to unlock, press against the skin, and click the purple button. They said "that's it" twice and called it "the easiest way to do your GLP-1." For disposal, they showed replacing the cap and said you're done when you hear the click.
The video is in English with what appears to be a Vietnamese caption beginning, suggesting it may serve a bilingual audience. The creator was responding to a viewer request for "some direction" on injection technique. No specific medication brand was named, and no dose was mentioned. The overall tone was reassuring, aimed at people nervous about needles.
Does the science back this up?
The mechanical steps are mostly correct for auto-injector pens, but the simplified framing leaves out information that actually affects whether the injection works. The FDA-approved labeling for semaglutide auto-injectors (used in Ozempic and Wegovy) specifies steps that this tutorial skips entirely.
A 2022 review by Drab et al. in Diabetes Therapy found that injection technique errors, including incorrect site rotation and failure to hold the pen in place, were associated with suboptimal glycemic outcomes. Specifically, not holding the pen pressed against the skin for the full recommended duration (typically 10 seconds for most GLP-1 pens) can cause medication leakage. The video says nothing about hold time. The creator also does not mention confirming the dose window is clear, checking expiration, or storing the pen correctly before use. These aren't nitpicks. They affect whether you actually get your medication.
What did they get wrong (or right)?
Credit where it's due: the cap removal, unlock twist, and button-press sequence is directionally accurate for many GLP-1 auto-injectors. The reassurance around needle anxiety is legitimate and reflects real patient experience data. Fear of self-injection is a documented barrier to adherence (Brod et al., 2014, Patient Preference and Adherence).
But the disposal guidance is wrong in a way that matters. Saying disposal means "just by putting this back on" and hearing a click is incomplete and potentially unsafe. Used injection pens are sharps waste. The FDA and CDC both require sharps to be placed in an approved sharps container, not simply recapped. Recapping does not make a used pen safe for household trash or recycling. This is a public health issue, not a minor technicality. Beyond that, the tutorial skips site rotation entirely. Repeated injection into the same spot causes lipohypertrophy, a fatty tissue buildup that reduces drug absorption (Blanco et al., 2013, Diabetes Research and Clinical Practice).
What should you actually know?
If you are using a GLP-1 pen for the first time, a 90-second TikTok is not a substitute for the instructions that come with your specific medication. Here is what the tutorial missed that actually matters.
- Hold the pen against your skin for the full duration specified in your medication guide, usually around 10 seconds, so the full dose is delivered.
- Rotate injection sites across your abdomen, thigh, or upper arm. Do not reuse the same spot.
- Check the dose window or indicator on your specific pen before injecting to confirm it is set correctly.
- Store your pen per manufacturer guidelines, typically refrigerated before first use, then at room temperature for a limited window.
- Dispose of used pens in an FDA-cleared sharps container, not by recapping and placing in the trash. Many pharmacies offer sharps disposal programs.
The creator's instinct to normalize injection for anxious patients is good. The execution left out the parts that keep patients safe and make the medication work.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
ricewashrepeat · TikTok creator
1.4K views on this video
How to use a GLP-1 pen The fear of needles doesn’t just disappear — but with practice, it gets easier. This step-by-step shows how simple the process can be for diabetic care. You’ve got this. One step at a time. #RiceWashRepeat #GLP1 #diabetes #healthtutorial #fyp Cách sử dụng bút GLP-1 Nỗi sợ kim tiêm không biến mất ngay — nhưng dùng quen rồi sẽ dễ hơn nhiều. Video này hướng dẫn từng bước để tiêm dễ dàng và an toàn hơn cho người tiểu đường. Cố lên nhé, từng bước một thôi.
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about fda-approved glp-1 pen labeling requires holding the pen against the?
FDA-approved GLP-1 pen labeling requires holding the pen against the skin for roughly 10 seconds after clicking, a step the video omits entirely.
What does the video say about blanco et al. (2013, diabetes research?
Blanco et al. (2013, Diabetes Research and Clinical Practice) linked repeated injection into the same site to lipohypertrophy, which reduces drug absorption. Site rotation was not mentioned in this tutorial.
What does the video say about used glp-1 pens?
Used GLP-1 pens are sharps waste under FDA and CDC guidelines. Recapping and placing in household trash is not compliant and creates needle-stick risk.
What does the video say about brod et al. (2014) confirmed?
Brod et al. (2014) confirmed that injection-related fear is a real barrier to GLP-1 adherence, so the creator's reassurance framing has legitimate clinical backing.
What does the video say about drab et al. (2022, diabetes therapy) found injection technique errors?
Drab et al. (2022, Diabetes Therapy) found injection technique errors were associated with worse glycemic control, meaning the steps a tutorial skips are not cosmetic details.
What does the video say about most pharmacies in the us offer sharps disposal containers?
Most pharmacies in the US offer sharps disposal containers or mail-back programs at low or no cost. Patients should ask their dispensing pharmacy.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by ricewashrepeat, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.